...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
【24h】

Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.

机译:gyrA和parC突变对喹诺酮耐药性,倍增时间和大肠杆菌超螺旋度的影响。

获取原文
获取原文并翻译 | 示例

摘要

Isogenic mutants derived from quinolone-susceptible isolate WT by introducing gyrA (S83L, D87G) and parC (S80I, E84K) mutations associated with quinolone resistance were characterized with respect to quinolone resistance, growth rate, and degree of global supercoiling. The latter was determined by use of a pair of reporter plasmids carrying supercoiling-dependent promoters pgyrA and ptopA, respectively, transcriptionally fused to the reporter gene bla coding for TEM-1 beta-lactamase. The quotient (Qsc) of the beta-lactamase specific activity determined for a mutant carrying either plasmid was taken as a measure of the degree of global supercoiling. These Qsc data were comparable to results obtained from the separation of topoisomers of plasmid pBR322 on chloroquine-containing agarose gels and indicate a reduced degree of negative supercoiling in resistant mutants relative to the parent, WT. The S83L mutation in gyrA had the strongest influence on quinolone resistance while leaving other parameters nearly unaffected. The gyrA double mutation (S83L plus D87G) had an effect on quinolone resistance similar to that of a single mutation. Phenotypic expression of the parC mutation (S80I) was dependent on the presence of at least one gyrA mutation. Expression of high-level fluoroquinolone resistance (ciprofloxacin MIC, > 4 micrograms/ml) required a combination of the gyrA double mutation and one parC mutation (S80I or E84K). Such mutants showed considerable alterations of growth rate, global supercoiling, or both. Introduction of a parC mutation affected neither the doubling time nor the degree of supercoiling, while the presence of the gyrA D87G mutation was associated with a significant reduction in the degree of DNA supercoiling.
机译:通过引入与喹诺酮抗性相关的gyrA(S83L,D87G)和parC(S80I,E84K)突变而衍生自喹诺酮敏感性分离株WT的同基因突变体,对喹诺酮抗性,生长速率和整体超螺旋程度进行了表征。后者是通过使用一对分别携带超螺旋依赖性启动子pgyrA和ptopA的报告质粒来确定的,它们被转录融合到编码TEM-1β-内酰胺酶的报告基因bla上。对于携带任一质粒的突变体确定的β-内酰胺酶比活性的商(Qsc)被用作整体超螺旋程度的量度。这些Qsc数据与在含氯喹的琼脂糖凝胶上分离质粒pBR322的拓扑异构体获得的结果相当,并且表明相对于亲本WT,抗性突变体中负超螺旋的程度降低。 gyrA中的S83L突变对喹诺酮耐药性的影响最大,而其他参数几乎不受影响。 gyrA双重突变(S83L加D87G)对喹诺酮耐药的影响与单一突变相似。 parC突变(S80I)的表型表达取决于至少一个gyrA突变的存在。要表达高水平的氟喹诺酮耐药性(环丙沙星MIC,> 4微克/毫升),需要结合gyrA双重突变和一个parC突变(S80I或E84K)。这样的突变体显示出生长速率,整体超螺旋或两者的显着改变。 parC突变的引入既不影响倍增时间也不影响超螺旋程度,而gyrA D87G突变的存在与DNA超螺旋程度的显着降低相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号